Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 28 Oct 2015
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 17 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2008 New trial record.